Mycoplasma pneumoniae primarily causes respiratory tract infections. Extrapulmonary manifestations are seen in 20-25% of cases. Cardiac involvement is rarely reported. We present a unique case of a pericardial mass and cardiac tamponade associated with a Mycoplasma pneumoniae pneumonia. This required emergency pericardial fenestration. The patient improved dramatically postoperatively on antibi...

Since Mycoplasma hyopneumoniae isolation in appropriate media is a difficult task and impractical for daily routine diagnostics, Nested-PCR (N-PCR) techniques are currently used to improve the direct diagnostic sensitivity of Swine Enzootic Pneumonia. In a first experiment, this paper describes a N-PCR technique optimization based on three variables: different sampling sites, sample transport m...

• DRAXXIN (tulathromycin) Injectable Solution administered as a single subcutaneous (SC) injection was safe and effective for the treatment of experimentally induced Mycoplasma bovis (M. bovis) respiratory infection in calves. • DRAXXIN significantly reduced percentage of days with pyrexia and lung lesions compared with saline. • Animals treated with DRAXXIN gained more weight than animals trea...

Genomic fingerprints of Acholeplasma laidlawii, Mycoplasma hominis, and Mycoplasma pneumoniae strains were obtained by Southern blot hybridization of the digested mycoplasmal DNAs with an rRNA gene probe. The hybridization patterns revealed genotypic heterogeneity among A. laidlawii and M. hominis strains and a remarkable degree of homogeneity among M. pneumoniae strains isolated from pneumonia...

Mycoplasma pneumoniae, first identified as the cause of Eaton agent pneumonia in 1962 by Chanock, Hayflick, and Barile, remains the only species of mycoplasma proven to be a human pathogen (Griffin and Crawford, 1969). It attacks mainly the respiratory system but is also a recognized cause of acute haemolytic anaemia (Peterson, Ham, and Finland, 1943) and erythema multiforme (Gordon and Lyell, ...